세계의 PBM(Pharmacy Benefit Management) 시장 규모, 점유율, 동향 분석 : 비즈니스 모델별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Pharmacy Benefit Management Market Summary

The global pharmacy benefit management market size was estimated at USD 747.08 billion in 2024 and is projected to reach USD 1,726.27 billion by 2033, growing at a CAGR of 9.9% from 2025 to 2033. This growth is attributed to the growing demand for cost-containment solutions in healthcare, and the shift toward value-based care and outcomes-driven healthcare models, which have motivated providers and payers to collaborate with PBMs to improve medication adherence, optimize formularies, and ensure better therapeutic outcomes.

In addition, regulatory changes and rising healthcare spending in emerging markets contribute to market growth.

Rising Costs of Prescription Medications & Increasing Therapeutic Complexity

As pharmaceutical prices continue to rise, especially for specialty drugs and innovative therapies, healthcare providers and payers are under increasing financial pressure to control expenses without sacrificing patient care. Simultaneously, treatment regimens have grown more complex, characterized by advanced biologics, targeted therapies, and personalized medicine. This complexity requires specialized management to ensure appropriate drug selection, dosing, and patient adherence. PBMs play a vital role in tackling these challenges by utilizing their expertise in formulary design, negotiating drug prices, and employing data-driven strategies to optimize therapeutic outcomes.

PBMs' ability to navigate the complexities of modern pharmacology while reducing unnecessary costs makes them essential for improving healthcare affordability and ensuring patient access to effective treatments.

Global Pharmacy Benefit Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmacy benefit management market report based on business model, end-use, and region.

• Business Model Outlook (Revenue, USD Billion, 2021 - 2033)
• Standalone PBM
• Health Insurance Providers
• Retail Pharmacy
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Commercial
• Federal
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Oceania
  • Australia
  • New Zealand
• Rest of World

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Business Model
  • 1.2.2. End-use
• 1.3. 1.3 Research Methodology
  • 1.3.1. Commodity flow analysis
  • 1.3.2. Information procurement
    • 1.3.2.1. Purchased database
    • 1.3.2.2. GVR'S internal database
    • 1.3.2.3. Primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Market Segmentation
• 2.3. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis

Chapter 4. Pharmacy Benefit Management Market: Business Model Estimates & Trend Analysis

• 4.1. Pharmacy Benefit Management Market: Business Model Segment Dashboard
• 4.2. Business Model Movement & Market Share Analysis, 2024 & 2033
• 4.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by Business Model
  • 4.3.1. Standalone PBM
    • 4.3.1.1. Standalone Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 4.3.2. Health Insurance Providers
    • 4.3.2.1. Health Insurance Providers Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 4.3.3. Retail Pharmacy
    • 4.3.3.1. Retail Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 5. Pharmacy Benefit Management Market: End-use Estimates & Trend Analysis

• 5.1. Pharmacy Benefit Management Market: End-use Segment Dashboard
• 5.2. End-use Movement & Market Share Analysis, 2024 & 2033
• 5.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by End-use
  • 5.3.1. Commercial
    • 5.3.1.1. Commercial Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 5.3.2. Federal
    • 5.3.2.1. Federal Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 6. Pharmacy Benefit Management Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.6. Oceania
  • 6.6.1. Australia
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.2. New Zealand
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. New Zealand market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market position analysis, 2024
• 7.4. List of Companies
  • 7.4.1. CVS Health
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Cigna
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Optum, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. MedImpact
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Anthem
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Change Healthcare
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Prime Therapeutics LLC
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. HUB International Limited
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Elixir Rx Solutions LLC
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Express Scripts Canada
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives